U.S. Biotech Stock News

Clarivate (NYSE:CLVT) has integrated its regulatory intelligence with Anthropic's Claude AI assistant. The collaboration embeds Clarivate's regulatory data directly into biopharma, biotech, and medtech AI workflows. The move is aimed at supporting regulatory affairs teams by keeping trusted data closer to day to day decision making. Clarivate focuses on data, analytics, and workflow tools for research driven industries, and life sciences is a core part of that mix. By plugging its...

CrowdStrike recently reported past fourth-quarter and full-year results showing higher revenue and its first positive quarterly GAAP net income, alongside new guidance for fiscal 2027, and followed this with browser- and cloud-focused security partnerships with Perplexity AI and Schwarz Digits’ STACKIT sovereign cloud in Europe. Together, these moves extend the Falcon platform deeper into AI-native workflows and EU-sovereign infrastructure, reinforcing CrowdStrike’s role in securing emerging...

Market snapshot: Westlake after recent price move Westlake (WLK) has pulled back around 1.9% over the past day, after a strong run in the past month and past 3 months, prompting some investors to reassess the stock’s recent momentum. See our latest analysis for Westlake. That 1 day share price pullback comes after a 7 day share price return of 8.6%, a 90 day share price return of 50.6%, and a 5 year total shareholder return of 32.3%. This suggests that momentum has been strong over longer...

In March 2026, Rapport Therapeutics reported a wider fourth-quarter and full-year 2025 net loss, while also filing new shelf registrations and granting Tenacia Biotechnology exclusive rights to develop and commercialize its clinical-stage candidate RAP-219 in Greater China in return for US$20 million upfront, potential milestone payments of about US$308 million, and tiered royalties. This licensing deal, combined with plans for global Phase 3 trials of RAP-219 in focal onset seizures,...

In March 2026, On Holding AG reported fourth-quarter 2025 sales of CHF 743.8 million and full-year 2025 sales of CHF 3.01 billion, alongside lower net income compared to the prior year. At the same time, the company issued 2026 guidance calling for at least 23% constant-currency net sales growth, implying reported revenue of at least CHF 3.44 billion and signaling confidence in its ability to extend its recent top-line momentum. Next, we’ll examine how this at least 23% constant-currency...

Hemisphere GNSS, a brand of CNH Industrial, has introduced the A65 GNSS antenna in partnership with Calian Group, targeting better interference rejection and easier upgrades for precision agriculture systems. Forrester Farm Equipment is acquiring AG-Industrial, expanding the CNH dealer network and deepening cooperation on parts and service support across North America. CNH Industrial (NYSE:CNH), trading at about $10.65, has a mixed recent performance, with a 13.9% return year to date but...

If you are wondering whether Toll Brothers is still reasonably priced after a strong run, you are not alone. The stock’s current valuation is a key question for many investors right now. The share price closed at US$136.69, with a 7.4% decline over the last 7 days and a 15.3% decline over the last 30 days, while the 1 year return sits at 31.4% and the 3 year and 5 year returns are 143.5% and 165.4% respectively. Recent news flow around Toll Brothers has focused on broader housing market...

In March 2026, Wyndham Hotels & Resorts increased its quarterly dividend to US$0.43 per share, appointed Amit Sripathi as Chief Financial Officer, promoted David Wilner to Chief Development Officer – North America, and was selected by ALMAL Real Estate Development to manage a new luxury Registry Collection hotel in Bali’s Nusa Dua enclave. Together, the higher dividend, leadership changes and expansion into upscale international projects highlight Wyndham’s focus on fee-based growth, capital...

Zillow Group (NasdaqGS:ZG) is rolling out expanded tools for so called accidental landlords who are renting out homes they did not initially plan to lease. The move comes as a near record share of listed rentals in the U.S. now comes from these unexpected landlords, reflecting a clear shift in housing market behavior. The new features aim to make it easier for homeowners to list, screen tenants and manage properties on Zillow's rentals platform. Zillow Group, trading at $42.15, is leaning...

Board appointment aligns with CCC Intelligent Solutions Holdings AI and platform focus CCC Intelligent Solutions Holdings (CCC) has appointed veteran enterprise software executive John Schweitzer to its Board, highlighting the company’s focus on data platforms, AI driven workflows, and scaled go to market execution across the insurance economy. See our latest analysis for CCC Intelligent Solutions Holdings. CCC’s recent 1 month share price return of 16.22% sits against a much weaker year to...

Kalshi recently announced a partnership with Brazilian broker XP Inc. to offer regulated prediction markets to XP clients holding international investment accounts, initially via the Clear Corretora platform and focused on financial and economic event-based contracts. This move introduces a new asset class alongside equities, ETFs, bonds, and derivatives on XP’s international platform, underscoring XP’s push to broaden product diversification and financial innovation for Brazilian investors...

In the past week, Ingram Micro Holding Corporation completed a US$200.00 million follow-on equity offering of 8,988,764 common shares at US$22.25 each, while also announcing a new US$100.00 million share repurchase program tied to secondary offerings by existing shareholders. This combination of fresh equity issuance, a major sell-down by Platinum Equity LLC, and a buyback authorization highlights a significant reshaping of Ingram Micro’s shareholder base without directly changing its...

In early March 2026, Freshworks Inc. reshaped its leadership by unifying its global sales organization under newly appointed Chief Revenue Officer Ian Tickle, while Chief Integrated Customer Growth Officer Mika Yamamoto prepared to depart after disclosing a planned sale of 32,577 shares under a Rule 10b5-1 plan. At the same time, the company reaffirmed its first-quarter and full-year 2026 earnings guidance and continued promoting its AI- and cloud-focused offerings, even as analysts weighed...

Infrastructure build out becomes the key story for Atmos Energy Atmos Energy (ATO) is ramping up its infrastructure program, with US$3.6b allocated in fiscal 2025 and a planned US$4.2b in 2026, supported by lower interest rates that ease financing costs. See our latest analysis for Atmos Energy. The stock’s recent move appears to reflect investors reacting to this heavier infrastructure spend, with a 7.17% 1 month share price return and a 28.61% 1 year total shareholder return suggesting...

Piper Sandler recently began covering Pathward Financial with an Overweight rating and a US$107.00 price objective, aligning with an Outperform average brokerage stance that reflects current analyst optimism. This fresh analyst attention could increase institutional and retail focus on Pathward’s role in digital banking partnerships and fee-based financial infrastructure. Next, we will examine how Piper Sandler’s new Overweight coverage interacts with analysts’ existing expectations for...

If you are wondering whether Valvoline at around US$33.60 offers fair value for the risk you are taking, this article walks through what the current price could imply about the company. The stock is up 16.4% year to date. However, it has seen a 4.7% decline over the last 7 days and a 13.6% decline over the last 30 days, with a 5.1% decline over the last year and a 32.1% gain over five years. These mixed returns suggest the market has been rethinking its stance on Valvoline. That makes it a...

Albemarle has completed the sale of a controlling stake in Ketjen Corporation's refining catalyst business, while keeping a minority interest. The transaction reshapes the company’s portfolio and sharpens its focus on lithium and energy storage activities. For investors watching NYSE:ALB, this move comes with the stock trading at $158.22 and showing very different results across timeframes. The share price is up 9.9% year to date and 114.0% over the past year, while the 3 year return is a...

Why Axsome’s Latest Legal and Regulatory Headlines Matter for Shareholders Axsome Therapeutics (AXSM) is back in focus as investors weigh a new shareholder investigation into past AXS-07 regulatory disclosures, alongside an upcoming FDA decision on AXS-05 for Alzheimer’s disease agitation. See our latest analysis for Axsome Therapeutics. At a share price of $156.08, Axsome’s 1 day share price return of 1.27% and 90 day share price return of 5.34% contrast with a 30 day share price return of a...

First Beijing Investment Ltd has become a major shareholder in Luckin Coffee (OTCPK:LKNC.Y) after acquiring over 107,000,000 shares. The purchase gives First Beijing Investment Ltd control of more than 5% of the company, crossing the threshold for a significant ownership stake. This change in the shareholder base introduces a new institutional holder that could influence future discussions around governance and strategy. Luckin Coffee operates a large coffee chain footprint in China,...

DENTSPLY SIRONA (NasdaqGS:XRAY) and Siemens Healthineers secured FDA clearance for the MAGNETOM Free.Max Dental Edition, described as the first MRI system dedicated to dental use. The company is preparing for a US launch, supported by clinical trial data and upcoming training programs for dental professionals. The system is designed to offer high contrast, non ionizing imaging for applications such as endodontics and TMJ assessment. At a current share price of $11.54, DENTSPLY SIRONA comes...

If you are wondering whether Hinge Health is attractively priced or already baking in a lot of optimism, this article is designed to help you frame that question clearly. The stock last closed at US$45.00, with a 16.1% gain over the past 30 days, but a 2.5% decline over the last week and a 1.2% decline year to date. This hints at shifting views on both its potential and its risks. Recent news coverage has focused on Hinge Health's position as a listed musculoskeletal care company, along with...

In March 2026, Tandem Diabetes Care announced that its FDA-cleared Tandem Mobi mobile app is now available to U.S. Android users via Google Play, enabling direct control of the Tandem Mobi automated insulin delivery system from select Google Pixel 6–10 and Samsung Galaxy S21–S25 smartphones. This expansion to Android significantly broadens the pool of potential users who can integrate Tandem Mobi into their existing devices, strengthening the appeal of Tandem’s connected diabetes management...

If you are wondering whether Copa Holdings at around US$110 per share is offering good value right now, looking closely at how it is priced versus its fundamentals can help you frame that decision. The stock has had a mixed run, with a 25.5% return over the last year and a 52.9% return over three years, alongside shorter term moves such as a 26.7% decline over the last 30 days and an 11.7% decline over the past week. Recent news around Copa Holdings has focused on its position in Latin...

Event context and recent share performance Smurfit Westrock (SW) has attracted attention after recent trading, with the share price closing at US$39.75. That puts the stock at around a 21% decline over the past month and a 7% decline over the past week. See our latest analysis for Smurfit Westrock. While the recent 1 month share price return of -20.94% has been sharp, the 90 day share price return of 6.88% and 3 year total shareholder return of 35.52% suggest longer term momentum has been...